Clinical Trial Update: Evaluation of Real-World Data on Ropeginterferon Alfa-2b in Patients With Polycythemia Vera: Insights From a Multicenter Study

View source ↗

Summary

A multicenter study is evaluating real-world data on ropeginterferon alfa-2b for polycythemia vera, with enrollment not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycythemia Vera

Drugs mentioned

• Ropeginterferon alfa-2b (ropeginterferon alfa-2b)

Snippet

Sponsor: Federico II University | Conditions: Polycytemia Vera | Status: NOT_YET_RECRUITING